Ordinary Adjustment | Solactive Transatlantic Healthcare Equity Index | Effective Date 8th April 2025
Solactive Transatlantic Healthcare Equity Index:
In the ordinary adjustment, the following composition will be implemented effective open 8th April 2025:
ABBOTT LABORATORIES |
AGILENT TECHNOLOGIES INC |
ALCON INC |
AMEDISYS INC |
AMGEN INC |
ARGENX SE |
BECTON DICKINSON AND CO |
BIOGEN INC |
BIOMARIN PHARMACEUTICAL INC |
BIOMERIEUX |
BOSTON SCIENTIFIC CORP |
COLOPLAST AS CLASS B |
COOPER COMPANIES INC |
DANAHER CORP |
DIASORIN SPA |
EDWARDS LIFESCIENCES CORP |
ENCOMPASS HEALTH CORP |
ESSILORLUXOTTICA |
GE HEALTHCARE TECHNOLOGIES INC |
GILEAD SCIENCES INC |
GLOBUS MEDICAL INC |
GSK PLC |
HALEON PLC |
HOLOGIC INC |
INTEGER HOLDINGS CORP |
JOHNSON & JOHNSON |
LABCORP HOLDINGS INC |
LONZA GROUP AG |
MEDTRONIC PLC |
MERCK & CO. INC. |
MERCK KGAA |
MERIT MEDICAL SYSTEMS INC |
METTLER-TOLEDO INTL |
NOVARTIS AG |
ORION OYJ CLASS B |
PFIZER INC |
QIAGEN NV |
QUEST DIAGNOSTICS INC |
RECORDATI SPA |
ROCHE HOLDING AG |
SANDOZ GROUP AG |
SANOFI SA |
SIEMENS HEALTHINEERS AG |
SONOVA HOLDING AG |
STERIS PLC |
STRAUMANN HOLDING AG |
STRYKER CORP |
THERMO FISHER SCIENTIFIC INC |
ZIMMER BIOMET HOLDINGS INC |
ZOETIS INC |